Market Overview

Tickers

Articles

Keywords

Search by keyword...
googlecse

Amylin Pharmaceuticals Announces Public Offering of Common Stock; No Amount Given

Eddie Staley, Benzinga Staff Writer
March 07, 2012 5:15 PM
+ Follow
Print
Email
Tickers: AMLN
Benzinga Share:

Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) today announced that it is offering to sell shares of its common stock in an underwritten public offering.

Credit Suisse Securities LLC is acting as sole book-running manager and underwriter in this offering.

(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Posted in: News, Offerings

 

Around the Web, We're Loving...

Obama Taking Action on Gun Background Check System
One Boston Suspect Dead, Police Search For Second
Can Netflix Be a Blockbuster Again? Click here to access an exclusive research report on NFLX from The Motley Fool

Most Popular

General Electric Posts Powerful First Quarter Earnings, Record Backlog
Infographic Explains Why Teens Are Leaving Facebook for Other Social Networks
UPDATE: BMO Capital Markets Lowers PT on International Business Machines on Weaker-Than-Expected Demand
Vertex News Lifts Biotech ETFs
UPDATE: Deutsche Bank Lowers PT on International Business Machine on Non-GAAP EPS Report
Benzinga Market Primer: Friday, April 19

Related Articles (AMLN)

Partner Network

Get Benzinga's News Delivered Free

Posts by Eddie Staley

Benzinga Professional

Subscribe